Serum Institute of India plans to launch Covovax by June: Adar Poonawalla

SII CEO Adar Poonawalla said on Saturday that its partnership for a Covid-19 vaccine with Novavax has shown excellent efficacy results. "We have applied for starting trials in India. Hope to launch Covocax by June 2021," Poonawalla said in a tweet. The new vaccine shall be launched under the brand name of Covovax, which SII is manufacturing in partnership with Novovax. The Pune-based global vaccine giant has sought permission from the DCGI to start domestic trials of the new product.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3t8Ua2b
via IFTTT